Transgene S.a annual depreciation and amortization
2021
2022
2023
2024
2025
Transgene S.a Depreciation & Amortization Growth & History (TNG)
Transgene S.a's depreciation and amortization was €1.3M for fiscal 2025.
View full Transgene S.a company overviewTransgene S.a annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.3M | €45,000 | +3.51% |
| 2024 | 2024-12-31 | €1.3M | −€291,000 | −18.51% |
| 2023 | 2023-12-31 | €1.6M | −€114,000 | −6.76% |
| 2022 | 2022-12-31 | €1.7M | −€835,000 | −33.12% |
| 2021 | 2021-12-31 | €2.5M | — | — |
Transgene S.a depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Transgene S.a's depreciation and amortization decreased from €2.5M to €1.3M, a change of −€1.2M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transgene S.a source filings ↗